FMC Corp vs MakeMyTrip Ltd — how do they compare? FMC Corp trades at $11.33 (market cap $1.36B), while MakeMyTrip Ltd trades at $54.25 (market cap $5.24B). The key difference: MakeMyTrip Ltd is far larger — about 3.9× FMC Corp's market cap, and FMC Corp pays a 2.95% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| FMC | MMYT | |
|---|---|---|
Market Cap | $1.36B | $5.24B |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $103.21 |
52-Week Low | $10.72 | $36.30 |
Enterprise Value | $5.50B | $5.89B |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
MMYT trades at $54.29, down 2.62% today amid a bearish technical signal, though it remains above key support at $52. The company shows strong revenue growth with $978M in 2025 and consistent earnings beats, but faces a high P/E of 153.56. Recent news highlights volatility from travel disruptions, yet analyst consensus remains strongly bullish with 73% buy ratings.
Outlook is mixed: robust fundamentals and analyst support suggest long-term potential, but high valuation and projected profit margin compression to 4.96% in 2026 pose risks. Investors should weigh growth against debt increases and market sensitivity to travel sector headwinds.
Trailing returns across standard periods
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →